Biostatistics Practice Questions

Q: A study evaluates the impact of a new diabetes management program on patient outcomes. Which method is the best to analyze the effectiveness of the program?

Randomized controlled trial. ***Randomized controlled trial*** - A **Randomized Controlled Trial (RCT)** is the **gold standard** for evaluating interventions because it minimizes bias by randomly assigning participants to either an intervention group or a control group. - This design allows for a direct comparison of outcomes, providing the strongest evidence of a program's **effectiveness** by controlling for confounding variables and ensuring that observed effects are likely due to the intervention. *Pre- and post-intervention comparison* - This method compares outcomes before and after an intervention in the same group of participants, but it lacks a **control group**. - Without a control group, it's difficult to attribute observed changes solely to the intervention, as other **confounding factors** or natural progression of the disease could also influence the results. *Cross-sectional survey* - A **cross-sectional survey** collects data at a single point in time, providing a snapshot of the prevalence of certain characteristics or outcomes. - This method is useful for describing populations but **cannot establish causality** or measure changes over time in response to an intervention. *Cohort study* - A **cohort study** follows a group of individuals over time to observe the development of outcomes, often comparing those exposed to a risk factor with those unexposed. - While useful for studying **risk factors** and disease incidence, it typically does not involve a controlled intervention and is more prone to **confounding biases** than an RCT when assessing program effectiveness.

Q: In a case-control study investigating the link between smoking and lung cancer, which measure of association is the most appropriate?

Odds ratio. ***Odds ratio*** - The **odds ratio** is the most appropriate measure of association for **case-control studies** because these studies select participants based on disease status, making direct calculation of incidence or relative risk impossible. - It approximates the **relative risk** when the disease is rare, providing a valid estimate of the association between the exposure (smoking) and the outcome (lung cancer). *Relative risk* - **Relative risk** is calculated in **cohort studies** where participants are followed over time to observe the incidence of disease in exposed versus unexposed groups. - It cannot be directly calculated in a **case-control study** because the study design ascertains cases and controls based on outcome, not exposure status. *Attributable risk* - **Attributable risk**, also known as risk difference, measures the absolute excess risk of disease in the exposed group compared to the unexposed group. - Like relative risk, it is primarily used in **cohort studies** to determine the benefit of removing an exposure, and it requires incidence data. *Incidence rate* - **Incidence rate** measures the frequency with which new cases of disease occur in a population at risk over a specified period. - It is a measure reported in **cohort studies** or surveillance studies, not typically in case-control studies, which are designed to compare exposures between cases and controls.

Q: From a population of 100,000, a sample of 100 women's hemoglobin is measured with a standard deviation of 2 gm%. What is the standard error of the mean?

0.2 gm%. ***0.2 gm%*** - The **standard error of the mean (SEM)** is calculated by dividing the population **standard deviation (SD)** by the square root of the **sample size (n)**. - Given SD = 2 gm% and n = 100, the SEM = 2 / √100 = 2 / 10 = **0.2 gm%.** *1 gm%* - This value would be obtained if the standard deviation was 10 gm% or if the sample size was 4 (2/√4 = 1), which is incorrect. - It does not reflect the given standard deviation or sample size in the standard error formula. *0.1 gm%* - This value would be correct if the standard deviation was 1 gm% (1/√100 = 0.1 gm%). - It does not align with the provided standard deviation of 2 gm%. *2 gm%* - This value represents the original **standard deviation** itself, not the standard error of the mean. - The standard error should be smaller than the standard deviation when the sample size is greater than 1.

Q: During a mass screening program for diabetes, a new test with a sensitivity of 85% and specificity of 90% is used. If the test is applied to a population with a low prevalence of diabetes, what is the most likely outcome?

Increased false positive results due to low prevalence. ***Increased false positive results due to low prevalence*** - In a population with **low disease prevalence**, even a test with high specificity will yield a significant number of **false positives** because there are many healthy individuals who will test positive. - While sensitivity and specificity are intrinsic to the test, the **positive predictive value (PPV)**, which reflects the likelihood of actually having the disease when testing positive, decreases dramatically with lower disease prevalence. *Increased true positive results due to high sensitivity* - While **high sensitivity** does mean that a large proportion of truly diseased individuals will be correctly identified as positive, the absolute number of **true positives** will be low if the disease itself is rare in the population. - The number of true positives is also directly limited by the **prevalence** of the disease. *Increased false negative results due to low prevalence* - **False negative results** are primarily influenced by the test's **sensitivity**, not directly by prevalence. A test with 85% sensitivity will miss 15% of true cases, regardless of how common or rare the disease is. - Low prevalence means there are fewer actual cases to begin with, so the absolute number of false negatives might be low, but the *proportion* of missed cases among true positives remains related to sensitivity. *Equal false positive and false negative results* - It is highly unlikely for **false positive** and **false negative** rates to be equal, as they are determined by different test characteristics (**specificity** and **sensitivity**, respectively) which are independent. - The impact of prevalence primarily skews the balance between false positives and true positives, and false negatives and true negatives.

Q: A researcher is conducting a study on the impact of air pollution on respiratory health. Which of the following study designs is best suited for this type of research?

Cohort study. ***Cohort study*** - A **cohort study** tracks a group of individuals over time, comparing those exposed to air pollution with an unexposed group to observe the development of respiratory outcomes. - This design allows for the calculation of **incidence rates** and establishes a temporal relationship between exposure and disease, which is crucial for studying environmental health impacts. *Case-control study* - A **case-control study** starts with individuals who already have the respiratory disease (cases) and compares their past exposure to air pollution with that of individuals without the disease (controls). - While useful for rare diseases, it is more prone to **recall bias** regarding past exposures and cannot directly measure incidence. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time. - It can determine prevalence but cannot establish a **temporal relationship** between air pollution exposure and the development of respiratory health issues. *Randomized controlled trial* - A **randomized controlled trial (RCT)** involves randomly assigning participants to an intervention group (e.g., reduced air pollution exposure) or a control group. - While ideal for establishing causality, it is **unethical and impractical** to intentionally expose people to air pollution to study its harmful effects.

Q: In a clinical trial, the difference in mean blood pressure between the treatment and control groups is found to be statistically significant. Which statistical test is most likely used?

t-test. ***Correct Answer: t-test*** - A **t-test** is used to compare the means of **two groups** (e.g., treatment and control) for a continuous variable, such as blood pressure. - The goal is to determine if the observed difference between the means is **statistically significant**, rather than due to random chance. - This is the **most appropriate test** for comparing mean blood pressure between two groups in a clinical trial. *Incorrect: Chi-square test* - The **Chi-square test** is used for analyzing **categorical data** (e.g., frequencies or proportions), not for comparing means of continuous variables like blood pressure. - It assesses whether there is a significant association between two or more categorical variables. *Incorrect: ANOVA* - **ANOVA (Analysis of Variance)** is used to compare the means of **three or more groups**, or when multiple factors are involved. - While it can technically be used for two groups, the **t-test is preferred** for simple two-group comparisons as it is more straightforward and provides equivalent results. *Incorrect: Fisher's exact test* - **Fisher's exact test** is similar to the Chi-square test and is used for **categorical data**, particularly when sample sizes are small in a 2x2 contingency table. - It is not appropriate for comparing the means of continuous variables across groups.

Q: A 60-year-old man presents with a chronic cough and is found to have a lung lesion on chest X-ray. What is the significance of high sensitivity in a diagnostic test for lung cancer?

It correctly identifies those with the disease. ***It correctly identifies those with the disease*** - A test with **high sensitivity** is good at ruling out disease when the result is negative because it has a low chance of missing true cases. - In lung cancer screening, high sensitivity helps ensure that individuals who actually have lung cancer are **identified**, reducing false negatives. *It incorrectly identifies those without the disease* - This statement describes a test with **low specificity**, where many healthy individuals are misidentified as having the disease (many false positives). - A high sensitivity test focuses on identifying true positives, not on incorrectly identifying healthy individuals. *It indicates the proportion of false negatives among all actual positives.* - The proportion of **false negatives among all actual positives** is the complement of sensitivity (1 - sensitivity). - High sensitivity implies a **low false-negative rate**, meaning few true cases are missed. *It indicates the proportion of true positives among all positive results.* - This describes **positive predictive value (PPV)**, which is the probability that a positive test result is truly positive. - While related to test utility, PPV is influenced by disease prevalence, whereas sensitivity is an intrinsic property of the test.

Q: In a community-based intervention, the incidence of a disease is found to decrease after vaccination. What study design is most appropriate to confirm vaccine efficacy?

Randomized controlled trial. ***Randomized controlled trial*** - A **randomized controlled trial (RCT)** is the most appropriate study design to confirm vaccine efficacy because it allows for a robust comparison between a vaccinated group and a control group (placebo or no intervention) by **randomly assigning participants** to each. - This design minimizes bias and allows researchers to establish a direct **cause-and-effect relationship** between the vaccine and the prevention of the disease by controlling for confounding factors. *Cohort study* - A **cohort study** observes groups over time, but participants are not randomized to receive the intervention (vaccine), which can introduce **selection bias** if those who choose to be vaccinated differ from those who do not. - While useful for studying prognosis or the effectiveness of interventions in real-world settings, it is less ideal for definitively establishing efficacy compared to an RCT due to the lack of **randomized assignment**. *Case-control study* - A **case-control study** compares individuals with a disease (cases) to those without the disease (controls) and looks back retrospectively for exposure to a risk factor (e.g., lack of vaccination). - This design is prone to **recall bias** and is suitable for rare outcomes, but it cannot directly measure vaccine efficacy or incidence in the same way an RCT can. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time, providing a snapshot of prevalence. - This design cannot establish temporality (which came first, exposure or outcome) and is therefore unsuitable for confirming vaccine efficacy or a **cause-and-effect relationship**.

Q: A randomized controlled trial of antihypertensives shows a p-value of 0.04 for the difference in blood pressure reduction. What is the most accurate interpretation?

4% chance of this or more extreme result if null true. ***4% chance of this or more extreme result if null true*** - A **p-value of 0.04** signifies that if the **null hypothesis** (no true difference between treatments) were true, there would be a **4% probability** of observing results as extreme as, or more extreme than, those obtained in the study. - This value is often compared to a predetermined **significance level (alpha)**, typically 0.05. Since 0.04 < 0.05, the result is considered statistically significant, leading to the rejection of the null hypothesis. *4% chance that the null hypothesis is true* - This statement incorrectly interprets a p-value as the **probability of the null hypothesis being true**. A p-value is the probability of observing the data, or more extreme data, given that the null hypothesis is true, not the probability of the null hypothesis itself. - The p-value does not provide the **prior probability** or the **posterior probability** of the null hypothesis being true. *96% chance that the alternative hypothesis is true* - This is an incorrect interpretation; a p-value does not indicate the **probability of the alternative hypothesis being true**. It is a measure related to the evidence against the null hypothesis, assuming the null is true. - The complement of the p-value (1 - p) does not represent the probability of the alternative hypothesis or the **power of the study**. *4% chance that the difference is due to random chance* - This interpretation is close but not entirely accurate; the p-value represents the probability of observing the data (or more extreme data) by **random chance alone** *if the null hypothesis were true*. - It does not state that the observed difference *is* due to random chance, but rather quantifies how likely such a difference is under the assumption of **no true effect**.

Q: In a study of 100 patients, the standard deviation of their blood pressure measurements is found to be 10 mmHg. What is the standard error of the mean?

1. ***Correct Option: 1*** - The **standard error of the mean (SEM)** is calculated by dividing the **standard deviation (SD)** by the square root of the **sample size (n)**. - Formula: SEM = SD / √n - Given an SD of **10 mmHg** and a sample size of **100**, SEM = 10 / √100 = 10 / 10 = **1 mmHg**. *Incorrect Option: 10* - This value represents the **standard deviation** of the sample, not the **standard error of the mean**. - The standard error accounts for the variability of sample means around the true population mean, which is always smaller than the standard deviation for n > 1. *Incorrect Option: 0.1* - This value would result if the standard deviation was 1 and the sample size was 100, or if the standard deviation was 10 and the sample size was 10,000. - It does not correctly reflect the given data of **SD = 10** and **n = 100**. *Incorrect Option: 2* - This value would result if the standard deviation was 20 and the sample size was 100, or if the standard deviation was 10 and the sample size was 25. - It does not align with the provided **standard deviation of 10** and a **sample size of 100**.

Question 1

A study evaluates the impact of a new diabetes management program on patient outcomes. Which method is the best to analyze the effectiveness of the program?

Accepted Answer

Randomized controlled trial

Answer

Pre- and post-intervention comparison

Answer

Cross-sectional survey

Answer

Cohort study

Question 2

In a case-control study investigating the link between smoking and lung cancer, which measure of association is the most appropriate?

Accepted Answer

Odds ratio

Answer

Relative risk

Answer

Attributable risk

Answer

Incidence rate

Question 3

From a population of 100,000, a sample of 100 women's hemoglobin is measured with a standard deviation of 2 gm%. What is the standard error of the mean?

Accepted Answer

0.2 gm%

Answer

2 gm%

Answer

1 gm%

Answer

0.1 gm%

Question 4

During a mass screening program for diabetes, a new test with a sensitivity of 85% and specificity of 90% is used. If the test is applied to a population with a low prevalence of diabetes, what is the most likely outcome?

Accepted Answer

Increased false positive results due to low prevalence

Answer

Increased true positive results due to high sensitivity

Answer

Increased false negative results due to low prevalence

Answer

Equal false positive and false negative results

Question 5

A researcher is conducting a study on the impact of air pollution on respiratory health. Which of the following study designs is best suited for this type of research?

Accepted Answer

Cohort study

Answer

Case-control study

Answer

Cross-sectional study

Answer

Randomized controlled trial

Question 6

In a clinical trial, the difference in mean blood pressure between the treatment and control groups is found to be statistically significant. Which statistical test is most likely used?

Accepted Answer

t-test

Answer

Chi-square test

Answer

ANOVA

Answer

Fisher's exact test

Question 7

A 60-year-old man presents with a chronic cough and is found to have a lung lesion on chest X-ray. What is the significance of high sensitivity in a diagnostic test for lung cancer?

Accepted Answer

It correctly identifies those with the disease

Answer

It incorrectly identifies those without the disease

Answer

It indicates the proportion of true positives among all positive results

Answer

It indicates the proportion of false negatives among all actual positives

Question 8

In a community-based intervention, the incidence of a disease is found to decrease after vaccination. What study design is most appropriate to confirm vaccine efficacy?

Accepted Answer

Randomized controlled trial

Answer

Cohort study

Answer

Case-control study

Answer

Cross-sectional study

Question 9

A randomized controlled trial of antihypertensives shows a p-value of 0.04 for the difference in blood pressure reduction. What is the most accurate interpretation?

Accepted Answer

4% chance of this or more extreme result if null true

Answer

4% chance that the null hypothesis is true

Answer

96% chance that the alternative hypothesis is true

Answer

4% chance that the difference is due to random chance

Question 10

In a study of 100 patients, the standard deviation of their blood pressure measurements is found to be 10 mmHg. What is the standard error of the mean?

Accepted Answer

1

Answer

10

Answer

0.1

Answer

2

Biostatistics — MCQs

Biostatistics — MCQs

On this page

Practice by Chapter

Want unlimited practice?